Systemic lupus erythematosus and ocular involvement: an overview

  title={Systemic lupus erythematosus and ocular involvement: an overview},
  author={Rosanna Dammacco},
  journal={Clinical and Experimental Medicine},
  • R. Dammacco
  • Published 1 May 2018
  • Medicine
  • Clinical and Experimental Medicine
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease of undefined etiology and with remarkably heterogeneous clinical features. Virtually any organ system can be affected, including the eye. SLE-related eye involvement can be diagnosed in approximately one-third of the patients and is usually indicative of disease activity. An early diagnosis and the adoption of suitable therapeutic measures are necessary to prevent sight-threatening consequences, especially in patients with… 

Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers

It is advised that a multidisciplinary team for the diagnosis and treatment of SLE should regularly include the presence of an ophthalmologist.

Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine

Ocular manifestations are prevalent in patients with SLE and the association with certain manifestations and other disease manifestations highlights the importance of collaboration between the ophthalmologist and rheumatologist.

Orbital myositis in systemic lupus erythematosus: a case-based review

It is essential to have a high index of suspicion for OM in SLE patients even when there is no systemic disease activity so that proper treatment is initiated early, and treatment with steroids led to the complete resolution of symptoms in most of these patients.

Bilateral Retinal Vasculitis as the First Presentation of Systemic Lupus Erythematosus

The number of case reports documenting this as a presenting symptom, often with minimal or no organ involvement, suggests that upon diagnosis, patients might benefit from a skilled ophthalmic evaluation.

Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review

The lack of biomarkers indicative of the potential risk of ocular ADRs hinders their prevention and emphasizes the need for an accurate risk vs. benefit assessment of these therapies for each patient.

Severe vaso-occlusive lupus retinopathy in the early stage of a pediatric patient with systemic lupus erythematosus: a case report

An early diagnosis and the prompt therapeutic measures are necessary to prevent sight-threatening consequences, especially in pediatric patients with SLE, as well as in adults with the disease.

Severe chemosis in lupus

He presented to the ophthalmology department with progressive blurred vision, metamorphopsia (distortion of objects), and bilateral conjunctival oedema that had developed over three months, showing high titres of antinuclear and anti-double strand DNA antibodies, low complement levels, moderate leucopenia, thrombocytopenia, andproteinuria.

Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement?

It is found that retinopathy is an early manifestation of the disease, and ophthalmologic screening might be considered for SLE patients at the time of diagnosis, especially for those with severe disease.

Unilateral branch retinal artery occlusion in a patient with systemic lupus erythematosus

This is a rare monocular vaso-occlusive retinopathy in SLE with mainly diffuse nonperfusion and small arterial and arteriolar occlusion in the retina, as distinct from more common vasculitis.

One after another retinal involvement in lupus.

Funduscopic examination revealed cotton-wool spots, narrowed branch retinal arteries, and retinal hemorrhage in her right eye, indicative of lupus retinopathy, as she fulfilled the Systemic Lupus International Collaborating Clinics classification criteria.



Ocular manifestations of systemic lupus erythematosus.

Ocular manifestations of lupus are fairly common, may be the presenting feature of the disease and can be sight-threatening and require urgent assessment by an ophthalmologist.

Ocular findings in systemic lupus erythematosus.

The concept of a fairly high incidence ofocular manifestations in systemic lupus erythematosus is no longer valid because today's patients, treated more successfully for systemic l upus, rarely present with ocular signs or symptoms.

Lupus Erythematosus Profundus Masquerading as Idiopathic Orbital Inflammatory Syndrome

A patient who had presented with ptosis evolving to orbital inflammation, which was consistent with IOIS, is described, who later developed extensive panniculitis and a final diagnosis of LEP was made.

Systemic lupus erythematosus

Systemic lupus erythematosus is a relapsing and remitting disease, and treatment aims are threefold: managing acute periods of potentially life-threatening ill health, minimizing the risk of flares during periods of relative stability, and controlling the less life- threatening, but often incapacitating day to day symptoms.

Ocular Manifestations of Systemic Lupus Erythematosus: A Review of the Literature

About one-third of patients suffering from systemic lupus erythematosus have ocular manifestations. The most common manifestation is keratoconjunctivitis sicca. The most vision threatening are

Optic nerve involvement in childhood onset systemic lupus erythematosus: Three cases and a review of the literature

Three children with SLE who presented with optic nerve involvement are reported, with optic neuritis being the first manifestation in one child and ischaemic optic neuropathy secondary to antiphospholipid syndrome.

Neuro‐ophthalmologic manifestations of systemic lupus erythematosus: a systematic review

The prognosis of neuro‐ophthalmologic manifestations in SLE is generally good because of their rapid response to glucocorticoids, and relapses of these manifestations may be reduced by the use of maintenance immunosuppression.

Systemic lupus erythematosus: An update for ophthalmologists.

Demyelinating disease in SLE: is it multiple sclerosis or lupus?

Bilateral transient keratoendotheliitis associated with systemic lupus erythematosus.

The case of a 45-year-old woman with long-standing SLE and severe central nervous system involvement in whom bilateral transient corneal edema developed that was responsive to topical and systemic corticosteroid treatment over a four-week period is reported.